About Lantheus Holdings, Inc
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
Market Cap
$6.75B
Employees
808
Listed Since
June 25, 2015
Industry
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Website
www.lantheus.comPhone
978 671-8001
Headquarters
331 TREBLE COVE ROAD
NORTH BILLERICA, MA 01862
CIK
0001521036